Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.32 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.32 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.32 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.32 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.32 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3892102 | 0.84 | PTGS1 (0.43) | HSD11B1LMNAHTTSMN1; SMN2KAT6A | |
| SCHEMBL5430636 | 0.83 | HTT (0.43) | HSD11B1LMNAHTTSMN1; SMN2KAT6A | |
| SCHEMBL28560059 | 0.81 | HDAC8 (0.39) | LMNAHTTSMN1; SMN2PABPC1RAB9A | |
| SCHEMBL6454098 | 0.80 | SLC22A2 (0.36) | HSD11B1KAT6AMEN1KMT2ARAB9A | |
| SCHEMBL103421 | 0.79 | LMNA (0.49) | LMNAHTTSMN1; SMN2GAAALDH1A1 | |
| SCHEMBL30099886 | 0.79 | LMNA (0.49) | LMNAHTTSMN1; SMN2GAAALDH1A1 | |
| Toluene SCHEMBL6508366 | 0.79 | LMNA (0.38) | LMNAHTTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL6915057 | 0.77 | HSD11B1 (0.42) | HSD11B1LMNAHTTMEN1KMT2A | |
| SCHEMBL57931 | 0.77 | TDP1 (0.45) | HSD11B1LMNAMEN1KMT2AESR1 | |
| SCHEMBL20658918 | 0.77 | HSD11B1 (0.42) | HSD11B1LMNAHTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100158860-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | STEINER SANDRA | 2010-06-24 | — | — | US | disclosed |
| US-20080274309-A1 | INK JET RECORDING MEDIA HAVING ENHANCED TOUGHNESS | FUJIFILM MANUFACTURING U.S.A. INC. (US) | 2008-11-06 | — | — | US | disclosed |
| EP-1633571-B1 | INK-JET RECORDING MEDIUM | FUJIFILM MFG EUROPE BV (NL) | 2008-07-16 | — | — | EP | disclosed |
| EP-1677989-B1 | RECORDING MEDIUM | FUJIFILM MFG EUROPE BV (NL) | 2008-01-30 | — | — | EP | disclosed |
| EP-1675727-B1 | RECORDING MEDIUM | FUJIFILM MFG EUROPE BV (NL) | 2007-07-18 | — | — | EP | disclosed |
| EP-1567361-B1 | INK-JET RECORDING MEDIUM | FUJIFILM MFG EUROPE BV (NL) | 2007-07-18 | — | — | EP | disclosed |
| US-20070009686-A1 | RECORDING MEDIUM | FUJI PHOTO FILM B.V. (NL) | 2007-01-11 | — | — | US | disclosed |
| US-20060222787-A1 | Recording medium | FUJI PHOTO FILM B.V. (NL) | 2006-10-05 | — | — | US | disclosed |
| US-20060222788-A1 | Recording medium | FUJI PHOTO FILM B.V. (NL) | 2006-10-05 | — | — | US | disclosed |
| US-20060181592-A1 | Ink-jet recording medium | FUJI PHOTO FILM B.V. (NL) | 2006-08-17 | — | — | US | disclosed |
| EP-1080937-B1 | Ink-receiving sheet for ink-jet printing comprising a mixture of gelatin and saccharides | FERRANIA SPA (IT) | 2003-03-12 | — | — | EP | disclosed |
| US-6387473-B1 | Receiving sheet for ink-jet printing comprising a surfactant combination | FERRANIA S.P.A. (IT) | 2002-05-14 | — | — | US | disclosed |
| EP-1101625-A2 | Receiving sheet for ink-jet printing comprising a copolymer | FERRANIA S.p.A. (IT) | 2001-05-23 | — | — | EP | disclosed |
| US-6210938-B1 | CONTACTING ALDEHYDE AND KETONE REACTANTS WITH CATALYTIC ANTIBODIES PRODUCED BY IMMUNIZING SUBJECT WITH STERILE SOLUTION OF ALDOL TRANSITION STATE IMMUNOCONJUGATE INCLUDING A SULFONE BETA-DIKETONE HAPTEN | THE SCRIPPS RESEARCH INSTITUTE | 2001-04-03 | — | — | US | disclosed |
| US-6207398-B1 | LYSING RED BLOOD CELLS IN A SAMPLE OF WHOLE BLOOD CONTAINING CYCLOSPORIN A, CONTACTING THE SAMPLE WITH EXCESS OF LABELED ANTI-CYCLOSPORIN ANTIBODY TO FORM A COMPLEX, SEPARATING UNBOUND ANTIBODY, CONTACTING COMPLEX WITH CYCLOSPORINS | DADE BEHRING INC. | 2001-03-27 | — | — | US | disclosed |
| EP-1080934-A1 | Ink-jet printing receiving sheet comprising gelatin and a metal salt | FERRANIA S.p.A. (IT) | 2001-03-07 | — | — | EP | disclosed |
| EP-1080935-A2 | Ink-jet print receiving sheet comprising a high-boiling organic solvent and an non-ionic surfactant | FERRANIA S.p.A. (IT) | 2001-03-07 | — | — | EP | disclosed |
| EP-1080937-A1 | Ink-receiving sheet for ink-jet printing comprising a mixture of gelatin and saccharides | FERRANIA S.p.A. (IT) | 2001-03-07 | — | — | EP | disclosed |
| EP-1080936-A2 | Receiving sheet for ink-jet printing comprising a surfactant combination | FERRANIA S.p.A. (IT) | 2001-03-07 | — | — | EP | disclosed |
| US-5066800-A | For coupling cephalosporins to quinolines(or derivatives) | HOFFMANN-LA ROCHE INC. (US) | 1991-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100158860-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | RFC1, RRP1B, RRBP1 | HSD11B1 1334/4885LMNA 2117/4885HTT 1853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.